KASID
Search
- Page Path
- HOME > Search
Review
- IBD
- Precision medicine in inflammatory bowel diseases
- Ashwin N. Ananthakrishnan
- Intest Res 2024;22(1):8-14. Published online November 9, 2023
- DOI: https://doi.org/10.5217/ir.2023.00087
-
Abstract
PDF
PubReader
ePub - Inflammatory bowel diseases comprising Crohn’s disease and ulcerative colitis have emerged as global diseases. Multiple distinct therapeutic mechanisms have allowed us to increase our rates of achieving remission and reducing permanent disease-related morbidity. However, there is limited data to inform relative positioning of different therapies. This review will summarize existing literature on use of clinical decision models to inform relative efficacy of one therapeutic mechanism compared to the other given individual patient characteristics. It will also demonstrate the value of serologic, transcriptomic (from biopsies), and microbiome-based biomarkers in identifying which therapy is most likely to work for a given patient. We will review the existing gaps in the literature in this field and suggest a path forward for future studies to better inform patient care, incorporating the principles of precision medicine in the management of inflammatory bowel disease.
-
Citations
Citations to this article as recorded by
- Prevalence, Clinical Characteristics, and Predictors of Difficult-to-Treat Inflammatory Bowel Disease in a Real-World Taiwanese Cohort
Shun-Wen Hsiao, Pei-Yuan Su, Chen-Ta Yang, Yang-Yuan Chen, Hsu-Heng Yen
Life.2026; 16(2): 197. CrossRef - Determination of correlation of clearance with clinical outcomes for inflammatory bowel disease
Diane R Mould, Maximillian Kutschera, Christian Primas, Sieglinde Reinisch, Gottfried Novacek, Cornelia Lichtenberger, Thierry Dervieux, Yunju Bae, Sun Hee Lee, Joon Ho Lee, Walter Reinisch
World Journal of Gastroenterology.2026;[Epub] CrossRef - In which patients with ulcerative colitis would filgotinib be effective?
Jihye Park
Intestinal Research.2025; 23(1): 1. CrossRef - Optimizing Infliximab Use in Real-World Inflammatory Bowel Disease: Insights from a Population Pharmacokinetic Model Integrating Intravenous and Subcutaneous Formulations
Sung Hoon Jung, Sang-Bum Kang
Gut and Liver.2025; 19(3): 299. CrossRef - Evolution of inflammatory bowel disease in Korea: a 60-year perspective on clinical and research development
Suk-Kyun Yang
Intestinal Research.2025; 23(3): 233. CrossRef - Assessing tuberculosis risk in Crohn’s disease patients receiving biologic therapies: real-world insights from Japan
Jung Won Lee, Yoo Min Han
Intestinal Research.2025; 23(3): 231. CrossRef - Oral–gut microbiome axis in a Korean cohort with inflammatory bowel disease and ankylosing spondylitis (INTEGRATE): a prospective and observational study protocol
Hyun Sik Kim, Bo-Hyung Kim, Bora Nam, Shin Ju Oh, Soo-Kyung Park, Sang Won Lee, Jae-Yun Lee, Sungsin Jo, Yeon-Ah Lee, June-Young Lee, Dong Il Park, Tae-Hwan Kim, Chang Kyun Lee
BMJ Open.2025; 15(8): e092075. CrossRef - Proteomic profiling of macrophages: effects of inflammatory activation and anti-inflammatory treatment with IBD therapeutics
Simone Lichtner, Kathrin Schunck, Johanna Frey, Janina Osti, Selina Dannheimer, Sabrina Schnur, Claus-Michael Lehr, Marc Schneider, Marius Hittinger
European Journal of Pharmaceutics and Biopharmaceutics.2025; 216: 114869. CrossRef - Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies
Jiyoung Yoon, Daein Kim, You Sun Kim
Intestinal Research.2025; 23(4): 430. CrossRef - Editorial: Another brick in the CDST wall: Authors' reply
Kyuwon Kim, Byong Duk Ye
Alimentary Pharmacology & Therapeutics.2024; 60(1): 87. CrossRef - Cytokine Profile in Predicting the Effectiveness of Advanced Therapy for Ulcerative Colitis: A Narrative Review
Hiroki Kurumi, Yoshihiro Yokoyama, Takehiro Hirano, Kotaro Akita, Yuki Hayashi, Tomoe Kazama, Hajime Isomoto, Hiroshi Nakase
Biomedicines.2024; 12(5): 952. CrossRef - Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects
Chahat Suri, Babita Pande, Tarun Sahu, Lakkakula Suhasini Sahithi, Henu Kumar Verma
Journal of Clinical Medicine.2024; 13(13): 3977. CrossRef
- Prevalence, Clinical Characteristics, and Predictors of Difficult-to-Treat Inflammatory Bowel Disease in a Real-World Taiwanese Cohort
- 9,098 View
- 341 Download
- 10 Web of Science
- 12 Crossref
First
Prev
